The goals of early palliation of pulmonary atresia with intact ventricular septum (PA-IVS) include the relief of cyanosis and ductal dependence by providing a reliable source of pulmonary blood flow, and the relief of right ventricular outflow tract (RVOT) obstruction to encourage forward flow and growth of right-sided
Definition:
Also known as Hypoplastic Right Heart Syndrome (HRHS)
It is a rare congenital cardiac lesion characterized by heterogeneous right ventricular development, an imperforate pulmonary valve, and possible extensive ventriculocoronary connections.
It is a type of congenital cyanotic heart disease, a severe form of Tetralogy of Fallot (TOF)
Newborn patients present cyanotic with high desaturation and pulmonary blood flow that depend on patent ductus arteriosus
Pulmonary atresia with intact interventricular septum Ramachandra Barik
PA/IVS is a rare congenital cardiac defect that consists of atresia of the pulmonary valve resulting in an absent connection between the right ventricular outflow tract (RVOT) and pulmonary arteries, and an intact ventricular septum that allows no connection between the right and left ventricles
Definition:
Also known as Hypoplastic Right Heart Syndrome (HRHS)
It is a rare congenital cardiac lesion characterized by heterogeneous right ventricular development, an imperforate pulmonary valve, and possible extensive ventriculocoronary connections.
It is a type of congenital cyanotic heart disease, a severe form of Tetralogy of Fallot (TOF)
Newborn patients present cyanotic with high desaturation and pulmonary blood flow that depend on patent ductus arteriosus
Pulmonary atresia with intact interventricular septum Ramachandra Barik
PA/IVS is a rare congenital cardiac defect that consists of atresia of the pulmonary valve resulting in an absent connection between the right ventricular outflow tract (RVOT) and pulmonary arteries, and an intact ventricular septum that allows no connection between the right and left ventricles
A 30-minute talk, presented as part of the weekly teaching activities in Alder Hey Children's Hospital (Liverpool, UK). It addresses PDA evaluation in children - starting with embryology & anatomy with the basis behind physiological closure versus patency after birth. What is the role of echo study in diagnosing/evaluating PDA? Modes used with some clear movies? Its limitations?
A 30-minute talk, presented as part of the weekly teaching activities in Alder Hey Children's Hospital (Liverpool, UK). It addresses PDA evaluation in children - starting with embryology & anatomy with the basis behind physiological closure versus patency after birth. What is the role of echo study in diagnosing/evaluating PDA? Modes used with some clear movies? Its limitations?
Pulmonary artery catheterisation, Cardiac surgeries, Non cardiac surgeries, LVEDD and PA pressure relationship, Technique and complications of PA placement
central venous pressure and intra-arterial blood pressure monitoring. invasiv...prateek gupta
central venous pressure and intra-arterial blood pressure monitoring. various sites for cvp and Ibp insertion. working principle for cvp and ibp. indication and complication. various waveform of cvp and ibp
The two major causes of acute right ventricular (RV) failure in ICU patients are acute cor pulmonale (ACP) during acute respiratory distress syndrome (ARDS) and ACP during acute massive pulmonary embolism (PE).
The increase in pulmonary vascular resistance (PVR) in ARDS can be secondary either to « structural » mechanisms related to lung injury per se and to « functional » mechanisms related to the effects of mechanical ventilation with positive end expiratory pressure (PEEP). The latter mechanism is enhanced when PEEP overdistends more than it recruits lung volume and when tidal volume (VT) is high. The recommended protective ventilation with low VT and PEEP adjusted to driving pressure can also reduce the RV afterload. A reduced central blood volume can also play a role in the increase in PVR (extension of the West’s zone 2). In this case, volume administration can reduce the PVR and improve the RV function. Finally, prone positioning also exerts a beneficial effect on RV afterload through a decrease in PVR (lung recruitment, decrease in hypoxic vasoconstriction, increase in central blood volume with decrease in the extent of zone 2).
In acute PE, RV dysfunction is associated with poor outcome. Thrombolytic treatment, which is indicated in cases of severe PE with shock, prevents hemodynamic decompensation in patients with intermediate risk PE, but also results in increased risk of severe hemorrhage and stroke. In the case of PE with low cardiac output and no RV dilatation, fluid administration can be indicated to improve cardiac output. In cases of systemic arterial hypotension, vasopressors such as norepinephrine can be indicated to restore adequate RV perfusion pressure. Indication of inotropic agents such as dobutamine, which improves the RV-pressure artery coupling should be evaluated individually. Surgical pulmonary embolectomy can be indicated when the thrombolytic therapy is contra-indicated in acute PE with shock.
Wellens syndrome. Wellens syndrome (also referred to as LAD coronary T-wave syndrome) refers to an ECG pattern specific for critical stenosis of the proximal left anterior descending artery. The anomalies described occur in patients with recent anginal chest pain, and do not have chest pain when the ECG is recorded.
Congenital defects can put a strain on the heart, causing it to work harder. To stop your heart from getting weaker with this extra work, your doctor may try to treat you with medications. They are aimed at easing the burden on the heart muscle. You need to control your blood pressure if you have any type of heart problem.
Changing your lifestyle can help control and manage high blood pressure. Your health care provider may recommend that you make lifestyle changes including:
Eating a heart-healthy diet with less salt
Getting regular physical activity
Maintaining a healthy weight or losing weight
Limiting alcohol
Not smoking
Getting 7 to 9 hours of sleep daily
CRISPR technologies have progressed by leaps and bounds over the past decade, not only having a transformative effect on
biomedical research but also yielding new therapies that are poised to enter the clinic. In this review, I give an overview of (i)
the various CRISPR DNA-editing technologies, including standard nuclease gene editing, base editing, prime editing, and epigenome editing, (ii) their impact on cardiovascular basic science research, including animal models, human pluripotent stem
cell models, and functional screens, and (iii) emerging therapeutic applications for patients with cardiovascular diseases, focusing on the examples of Hypercholesterolemia, transthyretin amyloidosis, and Duchenne muscular dystrophy.
A post-splenectomy patient suffers from frequent infections due to capsulated bacteria like Streptococcus
pneumoniae, Hemophilus influenzae, and Neisseria meningitidis despite vaccination because of a lack of
memory B lymphocytes. Pacemaker implantation after splenectomy is less common. Our patient underwent
splenectomy for splenic rupture after a road traffic accident. He developed a complete heart block after
seven years, during which a dual-chamber pacemaker was implanted. However, he was operated on seven
times to treat the complication related to that pacemaker over a period of one year because of various
reasons, which have been shared in this case report. The clinical translation of this interesting observation
is that, though the pacemaker implantation procedure is a well-established procedure, the procedural
outcome is influenced by patient factors like the absence of a spleen, procedural factors like septic measures,
and device factors like the reuse of an already-used pacemaker or leads.
Transcatheter closure of patent ductus arteriosus (PDA) is feasible in low-birth-weight infants. A female baby was born prematurely with a birth weight of 924 g. She had a PDA measuring 3.7 mm. She was dependent on positive pressure ventilation for congestive heart failure in addition to the heart failure medications. She could not be discharged from the hospital even after 79 days of birth, and even though her weight reached 1.9 kg in the neonatal intensive care unit. We attempted to plug the PDA using an Amplatzer Piccolo Occluder, but the device failed to anchor. Then, the PDA was plugged using a 4-6 Amplatzer Duct Occluder using a 6-Fr sheath which was challenging.
Accidental misplacement of the limb lead electrodes is a common cause of ECG abnormality and may simulate pathology such as ectopic atrial rhythm, chamber enlargement or myocardial ischaemia and infarction
A Case of Device Closure of an Eccentric Atrial Septal Defect Using a Large D...Ramachandra Barik
Device closure of an eccentric atrial septal defect can be challenging and needs technical modifications to avoid unnecessary complications. Here, we present a case of a 45-year-old woman who underwent device closure of an eccentric defect with a large device. The patient developed pericardial effusion and left-sided pleural effusion due to injury to the junction of right atrium and superior vena cava because of the malalignment of the delivery sheath and left atrial disc before the device was pulled across the eccentric defect despite releasing the left atrial disc in the left atrium in place of the left pulmonary vein. These two serious complications were managed conservatively with close monitoring of the case during and after the procedure.
Trio of Rheumatic Mitral Stenosis, Right Posterior Septal Accessory Pathway a...Ramachandra Barik
A 57-year-old male presented with recurrent palpitations. He was diagnosed with rheumatic mitral stenosis, right posterior septal accessory pathway and atrial flutter. An electrophysiological study after percutaneous balloon mitral valvotomy showed that the palpitations were due to atrial flutter with right bundle branch aberrancy. The right posterior septal pathway was a bystander because it had a higher refractory period than the atrioventricular node.
Percutaneous balloon dilatation, first described by
Andreas Gruentzig in 1979, was initially performed
without the use of guidewires.1 The prototype
balloon catheter was developed as a double lumen
catheter (one lumen for pressure monitoring or
distal perfusion, the other lumen for balloon inflation/deflation) with a short fixed and atraumatic
guidewire at the tip. Indeed, initially the technique
involved advancing a rather rigid balloon catheter
freely without much torque control into a coronary
artery. Bends, tortuosities, angulations, bifurcations,
and eccentric lesions could hardly, if at all, be negotiated, resulting in a rather frustrating low procedural success rate whenever the initial limited
indications (proximal, short, concentric, noncalcified) were negated.2 Luck was almost as
important as expertise, not only for the operator,
but also for the patient. It is to the merit of
Simpson who, in 1982, introduced the novelty of
advancing the balloon catheter over a removable
guidewire, which had first been advanced in the
target vessel.3 This major technical improvement
resulted overnight in a notable increase in the procedural success rate. Guidewires have since evolved
into very sophisticated devices.
Optical coherence tomography-guided algorithm for percutaneous coronary intervention. Vessel diameter should be assessed using the external elastic lamina (EEL)-EEL diameter at the reference segments, and rounded down to select interventional devices (balloons, stents). If the EEL cannot be identified, luminal measures are used and rounded up to 0.5 mm larger for selection of the devices. Optical coherence tomography (OCT)-guided optimisation strategies post stent implantation per EEL-based diameter measurement and per lumen-based diameter measurement are shown. For instance, if the distal EEL-EEL diameter measures 3.2 mm×3.1 mm (i.e., the mean EEL-based diameter is 3.15 mm), this number is rounded down to the next available stent size and post-dilation balloon to be used at the distal segment. Thus, a 3.0 mm stent and non-compliant balloon diameter is selected. If the proximal EEL cannot be visualised, the mean lumen diameter should be used for device sizing. For instance, if the mean proximal lumen diameter measures 3.4 mm, this number is rounded up to the next available balloon diameter (within up to 0.5 mm larger) for post-dilation. MLA: minimal lumen area; MSA: minimal stent area;NC: non-compliant
Brugada syndrome (BrS) is an inherited cardiac disorder,
characterised by a typical ECG pattern and an increased
risk of arrhythmias and sudden cardiac death (SCD).
BrS is a challenging entity, in regard to diagnosis as
well as arrhythmia risk prediction and management.
Nowadays, asymptomatic patients represent the majority
of newly diagnosed patients with BrS, and its incidence
is expected to rise due to (genetic) family screening.
Progress in our understanding of the genetic and
molecular pathophysiology is limited by the absence
of a true gold standard, with consensus on its clinical
definition changing over time. Nevertheless, novel
insights continue to arise from detailed and in-depth
studies, including the complex genetic and molecular
basis. This includes the increasingly recognised
relevance of an underlying structural substrate. Risk
stratification in patients with BrS remains challenging,
particularly in those who are asymptomatic, but recent
studies have demonstrated the potential usefulness
of risk scores to identify patients at high risk of
arrhythmia and SCD. Development and validation of
a model that incorporates clinical and genetic factors,
comorbidities, age and gender, and environmental
aspects may facilitate improved prediction of disease
expressivity and arrhythmia/SCD risk, and potentially
guide patient management and therapy. This review
provides an update of the diagnosis, pathophysiology
and management of BrS, and discusses its future
perspectives.
The Human Developmental Cell Atlas (HDCA) initiative, which is part of the Human Cell Atlas, aims to create a comprehensive reference map of cells during development. This will be critical to understanding normal organogenesis, the effect of mutations, environmental factors and infectious agents on human development, congenital and childhood disorders, and the cellular basis of ageing, cancer and regenerative medicine. Here we outline the HDCA initiative and the challenges of mapping and modelling human development using state-of-the-art technologies to create a reference atlas across gestation. Similar to the Human Genome Project, the HDCA will integrate the output from a growing community of scientists who are mapping human development into a unified atlas. We describe the early milestones that have been achieved and the use of human stem-cell-derived cultures, organoids and animal models to inform the HDCA, especially for prenatal tissues that are hard to acquire. Finally, we provide a roadmap towards a complete atlas of human development.
The treatment of patients with advanced acute heart failure is still challenging.
Intra-aortic balloon pump (IABP) has widely been used in the management of
patients with cardiogenic shock. However, according to international guidelines, its
routinary use in patients with cardiogenic shock is not recommended. This recommendation is derived from the results of the IABP-SHOCK II trial, which demonstrated
that IABP does not reduce all-cause mortality in patients with acute myocardial infarction and cardiogenic shock. The present position paper, released by the Italian
Association of Hospital Cardiologists, reviews the available data derived from clinical
studies. It also provides practical recommendations for the optimal use of IABP in
the treatment of cardiogenic shock and advanced acute heart failure.
Left ventricular false tendons (LVFTs) are fibromuscular
structures, connecting the left ventricular
free wall or papillary muscle and the ventricular
septum.
There is some discussion about safety issues during
intense exercise in athletes with LVFTs, as these
bands have been associated with ventricular arrhythmias
and abnormal cardiac remodelling. However,
presence of LVFTs appears to be much more common
than previously noted as imaging techniques
have improved and the association between LVFTs
and abnormal remodelling could very well be explained
by better visibility in a dilated left ventricular
lumen.
Although LVFTsmay result in electrocardiographic abnormalities
and could form a substrate for ventricular
arrhythmias, it should be considered as a normal
anatomic variant. Persons with LVFTs do not appear
to have increased risk for ventricular arrhythmias or
sudden cardiac death.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
10. Image: Giglia et al, Circulation
Potential of adverse outcome after
RV decompression:
RV to coronary
Fistula without
coronary stenosis
Potential RV steal
phenomenon
RV to coronary Fistula
with proximal ± distal
coronary stenosis
Potential RV steal/
ischemia
RV to coronary Fistula
with Coronary
occlusion/ atresia
Potential Isolation
and MI
11. Ventriculocoronary connections
With coronary
obstructive lesions,
normal aortic
diastolic pressure
insufficient to drive
coronary blood flow
Palliative measures
like BT shunt further
lower aortic diastolic
pressure coronary
ischemia
In RVDCC,
myocardial perfusion
sustained by
retrograde coronary
flow from
hypertensive RV,
during systole
Any decrease in
RVSP by RV
decompressive
procedures
coronary ischemia
13. Atrial septum
PFO or OS ASD with
obligatory R- L shunt
Oxygenated pulmonary
venous blood shunts L-
to-R across TV
perfuses the
myocardium
Nonrestrictive flow is
essential
Subcostal view: IAS with
aneurysmal flap, R-L shunt
Image: pedcards.com
14. Associated abnormalities
LPA coarctation at site of PDA insertion
Bilateral PDAs or MAPCAs when PAs non-confluent
Endocardial fibroelastosis, ventricular dysfunction
LV outflow tract obstruction
Aneurysm of septum primum
15. Procedures in
newborn period
Being a condition with PDA-
dependent pulmonary
circulation, intervention is almost
always required in neonatal
period
16. Goal: To increase
pulmonary blood flow
Well-developed RV, mild/
no TR, no RVDCC
Surgical or transcatheter
pulmonary valvotomy, or
RVOT reconstruction
Goal: To enable RV to provide
pulmonary circulation
Severe RV hypoplasia,
RVDCC
PGE1, PDA stent or
systemic- PA shunt
17. Is RV size adequate to support 2-
ventricle repair?
(i) Presence of three portions of the RV i.e.
tripartite, bipartite vs. unipartite
(ii) TV annulus diameter and its z-score
(iii) TV/MV diameter ratio >0.5 & TV z-score >
-2.5 possibility of 2-ventricle repair
18. Is there an infundibulum? Is MPA
in continuity with the imperforate
pulmonary valve?
Transcatheter RF valvotomy or RVOT
transannular patch Growth of the
hypoplastic RV is stimulated
Simultaneous PDA stenting or modified BT
shunt allows for adequate pulmonary blood
flow while RV is allowed to grow
19. Pulmonary valvotomy
Well-developed tripartite RV
Mild or no TR
No significant RV-CACs
BPV/ transcatheter wire perforation,
laser or radiofrequency assisted
OR
Surgical valvotomy
Ductal patency may be maintained by
PGE before the procedure
Image: Thoracickey
20. Dilated – normal sized - mildly
hypoplastic RV
RV size ≥ 2/3rd of normal
TV Z score 0 to -2
Consider surgical valvotomy with RVOT
reconstruction (RVOTR)
If additional source of PBF felt necessary,
systemic-to-PA shunt may be simultaneously
placed
21. RVOT Reconstruction Surgery
For fixed obstruction at subvalvar or annulus level:
1] Initially, RV-CACs are ligated reversibly, off CPB.
If ligation is not tolerated only shunt surgery
If no WMA or s/o injury ligation is completed
2] Relief of RVOTO performed:
Infundibular resection + TAP or surgical valvotomy
3] ASD is snared to achieve mild restriction - To encourage TV
flow
*If mostly RVDCC Single ventricle pathway
22. Role of Post-op. PGE1
Post- procedure, cyanosis may persist
Cause: Low RV compliance from myocardial
hypertrophy or fibrosis Elevated RV diastolic
pressure elevated RA pressure R-L shunt
through the foramen ovale
Adequate PBF may not be achieved for days to
weeks
May continue PGE1 in a low dose to maintain
ductus patency
23. RVOT Patch + arterial shunt
RVOTR + BT
Shunt
ASD and
Shunt can be
closed: 2VR
TV & RV
growth
failure:
BDGS
RV moderate
sized:
1 ½ VR
24. Low cardiac output syndrome
Following RVOTR & modified BT shunt:
1) Due to low diastolic pressure or
unrecognized RVDCC with myocardial
ischemia
2) Preferential pulmonary blood flow
as PVR very low and SVR high
3) Due to “Circular shunt”: when
trans-annular patch (resulting in
pulmonary regurgitation) is combined
with BT shunt.
Image: Ultrasound Obgyn
Blood flow: LA -> LV -> Aorta -> BT
shunt -> PA -> Retrograde into RV,
across RVOT -> Retrograde into RA,
across TV -> LA, across the ASD
25. Severely Hyoplastic RV
Pulmonary blood supply depends
entirely on systemic- pulmonary
connections
Systemic venous return reaches RA->
PFO -> LA
Q.1. Adequacy of PDA to sustain
pulmonary blood flow?
Q. 2. Adequacy of ASD for
decompression of systemic venous
return to LA?
Management option is to perform
systemic-PA shunt or PDA stent
26. Systemic-PA shunt or PDA stent
Indications:
Severe RV hypoplasia (TV Z score < -
4.5)
RVDCC (these patients are candidates
for eventual SVR)
Implantation of a stent in the PDA can
achieve the same end
Image rch.org.edu
27. Balloon atrial septostomy
If systemic-to-pulmonary artery shunt
contemplated, with presumed single-ventricle
pathway
Unrestrictive atrial communication necessary
If restrictive PFO, BAS to be done
30. Image: Pediat Therapeut 2012
4F JR2- JR4- Tip placed close
to PV- AP & Lat views
Atretic PV perforated with stiff
end of regular guide wire/
CTO guide wire/ Laser/ RF
perforation wire
5 mm Gooseneck snare placed
retrograde (FA PDA MPA)
Balloon catheter advanced
across perforated PV, over wire
(± veno-arterial loop)
Serial balloon valvuloplasty (3
mm PTCA balloon to 6-8 mm
balloons)
• Femoral v. & a. access
preferred over
umbilical (easier
catheter
manipulation)
• Heparin 50-100 U/kg
(target ACT> 200 s)
31. Hybrid approach
Sternotomy followed by placement of a purse
string suture in RV free wall, at a suitable location
aiming at the RVOT/ PV
Advance needle via the purse-string suture,
towards PV
Using TEE, perforate the PV
Advance guidewire and remove needle
Guide wire position confirmed by fluoroscopy
4 French sheath placed over guidewire and
secured by the surgeon
Serial balloon dilatations performed
32. Post-procedure role of PGE1
Dynamic obstruction of RVOT secondary to strong
contraction of the hypertrophic RV infundibulum
noted immediately after successful BPV
Continue PGE1 ±βblocker dynamic sub-PS may
resolve in a few days as RV hypertrophy resolves
RV volume decreases compared to pre-
intervention volume by approx. 40-50%
Continue PGE1RV volume increases back to
pre-intervention volume by approx. 3 weeks
34. Types of PDA in PA IVS
Usual: normal origin from
proximal descending aorta and a
short straight course with
constriction at insertion onto
MPA
Less common: More proximal
origin from aortic arch, opposite
origin of LSCA, at acute angle
Image: Alwi, Ann Pediatr Cardiol. 2008
35. 4F long sheath tip
positioned near the
ampulla
Using 4F JR catheter,
0.014” guidewire
passed, Ao PDA
MPA RV RA IVC
3.5 mm-4.5mm
diameter pre-mounted
stent positioned
balloon inflated and
stent expanded
balloon deflated
Post-expansion
angiogram: Entire
length of ductus is
covered by stent; no
encroachment of origin
of branch PA
PGE1 turned off before procedure
Femoral artery cannulated with 4F sheath
Heparin 50 units/kg, repeated every 1-1 ½ hour
Image: Alwi, Ann Pediatr Cardiol. 2008
37. Severely
hypoplastic
RV, RVDCC,
failed attempt
to induce TV
growth
Good sized,
tripartite RV,
successful
attempt to
induce TV
growth
Fontan
pathway
2VR-
Valvotomy/
RVOTR-
infundibular
resection &
patch
Image: J Pediatr Cardiol Surg, Thoracickey
38. Image: EJCTS 2011
Group A:
TV Z-score >-2.5
Good infundibulum,
Membranous atresia
Tripartite RV
No major sinusoids
Variable TR
Valvotomy & dilation
Dilation of restenosis,
RVOTR or TV repair
Group B
TV Z-score -2.5 to -4.5
Patent Infundibulum,
Subvalvular PS
Bipartite RV
Major sinusoids ±
Variable TR
Valvotomy & dilation, PDA
stenting ± BAS
TAP + modified BT shunt
RVOTR Or
BDGS (1 ½ VR) if RV fails
to develop*
Group C
TV Z-score < -4.5
Absent infundibulum,
Muscular atresia
Unipartite RV
Major sinusoids
Usually competent TV
PDA stenting or modified
BT shunt
± BAS
BDGS
Fontan/ Cardiac
transplantation*
*If extreme TR
Starnes approach
39. Intermediate RV size
If no fixed RVOTO (e.g. small PV annulus):
Reasonable to wait 3–4 years (with interim
valvotomy & PDA stenting) in anticipation of
RV growth.
If failure of RV growth: bidirectional Glenn
shunt and closure of ASD (1½ ventricle
repair) may be performed.
Aim: to retain the RV in the circulation if it is
capable of maintaining even part of
Pulmonary Blood Flow
40. One-and-half ventricle repair
The heart is
surgically septated (may
include ASD closure, RV-
PA conduit).
Additionally, a superior
cavopulmonary shunt is
created.
BDGS provides preload
reduction for the limited
right heart, thereby
avoiding right heart
failure.
41. Advantages of one-and-half
repair over BDGS:
No increase in LV volume load (as
no ASD)
Systemic saturation is complete
No risk of paradoxical emboli
43. TV repair for TS or TR
Valvar stenosis can be improved by BPV or
open valvoplasty. By open valvoplasty,
division of fused commissures/ fused papillary
muscles can be performed
If TV insufficiency significant-> valvar repair
44. Dysplastic TV with Marked TR / Ebstein
malformation
Difficult to manage, high mortality
Systemic to PA shunt may relieve cyanosis, but
combination of increased LVVO ( from shunt), and RVVO
(from TR) often induces cardiac failure
If patient requires placement of RVOT patch when 2VR
is considered-> PR results; 2 regurgitant valves (TV and
PV) in series make adequate C.O unlikely -> repair/
replacement of TV required
45. Dysplastic TV with Marked TR /
Ebstein malformation
Contemporary approach:
Convert to tricuspid
atresia, (Starnes)+
construct systemic-PA
shunt
Later cavopulmonary
palliation
Image: Sakurai, JTCVS, 2018
46. Closing the ASD
If right heart structures
fail to grow, or patient
remains too cyanotic
If ASD too large, size of
ASD should be
reduced
Device closure may be
performed if trial of
balloon occlusion is
tolerated
47. Heart failure from PR
In infants who have had surgical
opening of the RV infundibulum
and the annulus of the valve
If PR significant Large RV
volume overload marked RV
enlargement & progressive right
heart failure
With progressive RV enlargement
-> pulmonary valve replacement
necessary
Image: JUM
48. Contemporary Approaches
Fetal treatment: in utero
valvotomies- reported at
about 28 weeks (23-32
weeks). Providing forward
flow encourages RV and TV
growth.
Transplantation: subset of
patients where there are
significant RV-CACs and no
continuation between aorta
and coronary a.
Intrauterine BPV
Image: Ultrasound Obstet Gynecol
50. Image: EJCTS 2011
Group A:
TV Z-score >-2.5
Good infundibulum,
Membranous atresia
Tripartite RV
No major sinusoids
Variable TR
Valvotomy & dilation
Dilation of restenosis,
RVOTR or TV repair
Group B
TV Z-score -2.5 to -4.5
Patent Infundibulum,
Subvalvular PS
Bipartite RV
Major sinusoids ±
Variable TR
Valvotomy & dilation, PDA
stenting ± BAS
TAP + modified BT shunt
RVOTR Or
BDGS (1 ½ VR) if RV fails
to develop*
Group C
TV Z-score < -4.5
Absent infundibulum,
Muscular atresia
Unipartite RV
Major sinusoids
Usually competent TV
PDA stenting or modified
BT shunt
± BAS
BDGS
Fontan/ Cardiac
transplantation*
*If extreme TR
Starnes approach
51. References
Nykanen DG. Pulmonary atresia and intact ventricular septum. In Ed.
Allen HD, Driscoll DJ, Shaddy RE, Feltes TF. Moss and Adam’s Heart
Disease in infants, children and adolescents. Seventh ed. Philadelphia,
Lippincott Williams and Wilkins
Burkholder H, Balaguru D. Pulmonary Atresia with Intact Ventricular
Septum: Management Options and Decision-making. Pediat Therapeut
2012, S5
Alwi M. Management Algorithm in Pulmonary Atresia With IVS.
Catheterization & Cardio-vascular Interventions 2006; 67:679–686
Alwi M. Stenting the ductus arteriosus. Case selection, technique and
possible complications. Ann Pediatr Cardiol. 2008;1: 38–45.
Chikkabyrappa SM, Loomba RS, Tretter JT. Pulmonary Atresia With an
Intact Ventricular Septum: Preoperative Physiology, Imaging, and
Management. Seminars in Cardiothoracic and Vascular Anesthesia ·
February 2018
Foker JE et al. Treatment algorithm for PA with IVS. Progress in Pediatric
Cardiology 2010;29:61–63
Pulmonary atresia with IVS: Long-term results of 1&1/2 ventricle repair.
Kagami et al. AnnThoracic Surgery 1995;60:1762-1764